Isoflavones are phytoestrogens have a similar chemical structure to the hormone estrogen. Isoflavones may have estrogens or anti-estrogenic effects and so it is considered as a SERM (Selective Estrogen Receptor Modulators). The soy Isoflavones is potentially a very rich source of estrogen and vitamin E and possesses properties like anti-oxidant and breast cancer cells suppressor. The soy Isoflavones is produced from the leaf, bark, seed, and shell of soy plant and the end products of soy Isoflavones can be made available in the form of powder, oil or wax. The increasing awareness about the consumption of soy Isoflavones in the diet and its benefits like prevention and cure of heart-related diseases, multiple cancers, asthma, diabetes are the major factors driving the demand of soy Isoflavones worldwide.
Europe Soy Isoflavones Market size was around USD XX billion in 2018. It is expected to grow at a CAGR of XX% to reach USD XX billion by 2023.
The Europe soy Isoflavones market is anticipated to register a considerable CAGR over the aforementioned forecast period owing to the increasing demand of soy Isoflavones from pharmaceutical and medical industry. Soy Isoflavones has the properties like antioxidant along with protecting against the bad cholesterol and atherosclerosis in cardiovascular diseases, thereby driving the demand of the soy Isoflavones market. The consumption of soy Isoflavones through food and food supplements reduces the risk of growth of cancer cells by reducing cell mitosis process. The growing demand of soy Isoflavones from cosmetics industry for protect sun damage, treating skin firming, wrinkles, and moisturize skin which also drives the Europe soy Isoflavones market.
But still, the over consumption of soy Isoflavones leads to the side effects like migraine, food allergies, and thyroid disorder and may hinder the use of the soy Isoflavones and restrain the Europe soy Isoflavones market.
This market is segmented by form, raw material, product type and application. By form it is segmented into powder, liquid and wax. By application it is segmented into Food and Beverages, Nutraceutical, Cosmetics and Others. By raw material it is further segmented into Genetically Modified and non-genetically Modified. By Product Type it is further segmented into Genistein, Daidzein and Glucitein. Nutraceutical was the leading application sector and accounted for USD 5.14 billion in 2015. Isoflavones extract is widely used in dietary supplements, nutraceutical, and pharmaceutical industries.
By geography the market is segmented into Spain, Germany, France, UK, and others. Europe is also emerging as a potential market for the same, because of its various health benefits. It is likely to witness a significant growth in the aforementioned forecast period.
The industry is not dominated by any major players. Some of the key companies in this industry include Fujicco Co., Ltd, Aushadhi Herbal, Tradichem S.L, Frutarom Ltd., Archer Daniels Midland, SK Bioland, Medisys Biotech Pvt. Ltd., Guzen Development, Nutra Green Biotechnology Co., Ltd., and HerboNutra.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Soy beverages
5.1.3 Functional Foods
5.1.4 Supplements and healthcare products
184.108.40.206 Bone Health
5.1.6 Y-o-Y Growth Analysis, By Application
5.1.7 Market Attractiveness Analysis, By Application
5.1.8 Market Share Analysis, By Application
5.2.5 Y-o-Y Growth Analysis, By Form
5.2.6 Market Attractiveness Analysis, By Form
5.2.7 Market Share Analysis, By Form
5.3 Raw Material
5.3.1 Genetically Modified (GM)
5.3.2 Non-genetically Modified (Non-GM)
5.4 Product Type
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Application
22.214.171.124 By Form
6.1.4 Market Attractiveness Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Application
184.108.40.206 By Form
6.1.5 Market Share Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Application
22.214.171.124 By Form
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Frutarom Industries Ltd.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Atlantic Essential Products, Inc.
8.3 Novapac Laboratories, Inc.
8.4 Archer Daniels Midland Company
8.5 SK Bioland Co., Ltd.
8.6 Medisys Biotech Pvt. Ltd.
8.7 Fujicco Co., Ltd.
8.8 NutraScience Labs
8.9 Alaska Spring Pharmaceuticals
8.10 Perennial Lifesciences Pvt. Ltd.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures